Monopar Therapeutics Inc (MNPR) is around the top of the Healthcare sector according to InvestorsObserver. MNPR received an overall rating of 33, which means that it scores higher than 33% of stocks. Additionally, Monopar Therapeutics Inc scored a 90 in the Healthcare sector, ranking it higher than 90% of stocks in that sector.
MNPR has an Overall Score of 33. Find out what this means to you and get the rest of the rankings on MNPR!